Clinical TrialsSearch results
Number of results: 433
Completed
- A phase III study of FPF3401
- Hyposelenemia
- Urabe Hiromi
- 2022-07-09
Completed
- A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Trial Evaluating HZN-001 (teprotumumab) Treatment in Japanese Patients with Active Thyroid Eye Disease
- Active thyroid eye disease
- Oyama Fujiyo
- 2021-11-26
Completed
- A Multicenter, Open-label, Uncontrolled Phase II study of ONO-4538 [immune-checkpoint inhibitor] for cutaneous angiosarcoma
- Advanced or recurrent cutaneous hemangiosarcoma
- Fujisawa Yasuhiro
- 2020-04-22
Completed
- A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of the Preventive Effect of Naldemedine on Opioid-Induced Constipation
- neoplasms
- Jun Hamano
- 2021-03-05
No Longer Recruiting
- Phase I study of MTC001 in patients with chronic ischemic heart failure
- Patients with chronic ischemic heart failure who are not eligible for left ventricular assist device
- Machino Takeshi
- 2021-05-10
No Longer Recruiting
- Follow-up Study After Investigator-Initiated Phase I Study of MTC001 for Chronic Ischemic Heart Failure.
- Chronic ischemic heart failure
- Machino Takeshi
- 2023-07-11
No Longer Recruiting
- CA209-7G8/ONO-4538-110:Phase 3
- High-risk Non-muscle Invasive Bladder Cancer That Is Persistent or Recurrent After Treatment With BC
- Hirashima Yoshinori
- 2021-05-28
Recruiting
- Validation study of local resection with left gastric artery lymphatic basin dissection for upper third early gastric cancer.
- Gastric Cancer
- Akashi Yoshimasa
- 2022-08-19
Recruiting
- Uric acid Reduction Ameliorates Transition to End-stage renal disease Study (URATE Study)
- hyperuricemia chronic kidney disease (CKD)
- Society for Research on chronic kidney disease and hyperuricemia
- 2008-12-15
Recruiting
- Trial to evaluate the assistance of surgery by visualizing the urinary tract using a fluorescent substance called indocyanine green during robot-assisted laparoscopic radical prostatectomy
- Prostate Cancer
- Negoro Hiromitsu
- 2024-08-26